WEDNESDAY, Sept. 12, 2018 -- Researchers say the first drug for children with Multiple Sclerosis vastly outperformed another common MS medication in a new clinical trial. Fingolimod (Gilenya) reduced relapse rates by 82 percent in patients aged 10... (Source: - Daily MedNews)

Read full article on


Follow Us on Twitter

Follow Us On Twitter - Image